Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs propofol for painless bronchoscopy under laryngeal mask ventilation
ChiCTR2100049000Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in bronchopulmonary diseases (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Incidence of blood pressure drop. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2100049000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049000.